Post-mastectomy radiation therapy in breast cancer patients with 1–3 positive lymph nodes: No one size fits all

Abdel-Rahman, 2019, Impact of postmastectomy radiotherapy on the outcomes of breast cancer patients with T1-2 N1 disease: an individual patient data analysis of three clinical trials, Strahlenther. Onkol., 195, 297, 10.1007/s00066-018-1343-x Abi Jaoude, 2019, Post-mastectomy radiation therapy in HER -2 positive breast cancer patients: analysis of the HERA Trial, Int. J. Radiat. Oncol. Biol. Phys. Balic, 2019, St. Gallen/Vienna 2019: a brief summary of the consensus discussion on the optimal primary breast cancer treatment, Breast Care, 14, 103, 10.1159/000499931 Barnett, 2012, Randomized controlled trial of forward-planned intensity modulated radiotherapy for early breast cancer: interim results at 2 years, Int. J. Radiat. Oncol. Biol. Phys., 82, 715, 10.1016/j.ijrobp.2010.10.068 Bergkvist, 2008, Axillary recurrence rate after negative sentinel node biopsy in breast cancer: three-year follow-up of the Swedish Multicenter Cohort Study, Ann. Surg., 247, 150, 10.1097/SLA.0b013e318153ff40 Christante, 2010, Using complications associated with postmastectomy radiation and immediate breast reconstruction to improve surgical decision making, Arch. Surg., 145, 873, 10.1001/archsurg.2010.170 Clinical Trials.gov [Internet]: National Library of Medicine (US), 2013 Clinical Trials.gov [Internet]: National Library of Medicine (US), 2018 Cosar, 2011, Postmastectomy irradiation in breast in breast cancer patients with T1-2 and 1-3 positive axillary lymph nodes: is there a role for radiation therapy?, Radiat. Oncol., 6, 28, 10.1186/1748-717X-6-28 de Boniface, 2017, SENOMAC Trialists’ Group. Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: the randomized controlled SENOMAC trial, BMC Cancer, 26, 379, 10.1186/s12885-017-3361-y Donker, 2014, Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial, Lancet Oncol., 15, 1303, 10.1016/S1470-2045(14)70460-7 EBCTCG, 2014, Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women in 22 randomised trials, Lancet, 383, 2127, 10.1016/S0140-6736(14)60488-8 Galimberti, 2018, Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial, Lancet Oncol., 19, 1385, 10.1016/S1470-2045(18)30380-2 Gentilini, 2012, Abandoning sentinel lymph node biopsy in early breast cancer? A new trial in progress at the European Institute of Oncology of Milan (SOUND: sentinel node vs observation after axillary UltraSouND), Breast, 21, 678, 10.1016/j.breast.2012.06.013 Giuliano, 2000, Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer, J. Clin. Oncol., 18, 2553, 10.1200/JCO.2000.18.13.2553 Goodman, 2018, 21-gene recurrence score assay predicts benefit of post-mastectomy radiotherapy in T1-2 N1 breast cancer, Clin. Cancer Res., 24, 3878, 10.1158/1078-0432.CCR-17-3169 He, 2015, Postmastectomy radiotherapy improves disease-free survival of high risk of locoregional recurrence breast cancer patients with T1-2 and 1 to 3 positive nodes, PLoS One, 10, 10.1371/journal.pone.0145972 Huo, 2015, Use of postmastectomy radiotherapy and survival rates for breast cancer patients with T1–T2 and one to three positive lymph nodes, Ann. Surg. Oncol., 22, 4295, 10.1245/s10434-015-4528-x Kim, 2017, Postmastectomy radiotherapy in patients with pT1-2N1 breast cancer treated with taxane-based chemotherapy: a retrospective multicenter analysis (KROG 1418), Cancer Res. Treat., 49, 927, 10.4143/crt.2016.508 Kyndi, 2008, Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group, J. Clin. Oncol., 26, 1419, 10.1200/JCO.2007.14.5565 Li, 2014, Risk factors for locoregional recurrence after postmastectomy radiotherapy in breast cancer patients with four or more positive axillary lymph nodes, Curr. Oncol., 21, e685, 10.3747/co.21.2000 McBride, 2014, Locoregional recurrence risk for patients with T1,2 breast cancer with 1-3 positive lymph nodes treated with mastectomy and systemic treatment, Int. J. Radiat. Oncol. Biol. Phys., 89, 392, 10.1016/j.ijrobp.2014.02.013 Merino, 2018, Risk factors for loco-regional recurrence in breast cancer patients: a retrospective study, Oncotarget, 9, 30355, 10.18632/oncotarget.25735 Miyashita, 2017, Minimal impact of postmastectomy radiation therapy on locoregional recurrence for breast cancer patients with 1–3 positive lymph nodes in the modern treatment era, Surg. Oncol., 26, 163, 10.1016/j.suronc.2017.03.003 Moo, 2013, Selection criteria for postmastectomy radiotherapy in t1–t2 tumors with 1 to 3 positive lymph nodes, Ann. Surg. Oncol., 20, 3169, 10.1245/s10434-013-3117-0 Muhsen, 2018, Most breast cancer patients with T1-2 tumors and one to three positive lymph nodes do not need postmastectomy radiotherapy, Ann. Surg. Oncol., 25, 1912, 10.1245/s10434-018-6422-9 Network NCC, 2019 Overgaard, 2007, Is the benefit of postmastectomy irradiation limited to patients with four or more positive nodes, as recommended in international consensus reports? A subgroup analysis of the DBCG 82 b&c randomized trials, Radiother. Oncol., 82, 247, 10.1016/j.radonc.2007.02.001 Pu, 2018, The role of postmastectomy radiation therapy in patients with immediate prosthetic breast reconstruction: a meta-analysis, Medicine (Baltimore), 97, e9548, 10.1097/MD.0000000000009548 Ragaz, 2005, Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year results of the British Columbia randomized trial, J. Natl. Cancer Inst., 97, 116, 10.1093/jnci/djh297 Recht, 2016, Postmastectomy radiotherapy: an American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update, J. Clin. Oncol., 34, 4431, 10.1200/JCO.2016.69.1188 Santa-Maria, 2015, Neoadjuvant therapy for early-stage breast cancer: current practice, controversies, and future directions, Oncology (Williston Park), 29, 828 Senkus, 2015, Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Ann. Oncol., 26, v8, 10.1093/annonc/mdv298 Shaitelman1 TAB, 2014, Hypofractionated whole breast irradiation results in less acute toxicity and improved quality of life at six months compared to conventionally fractionated whole breast irradiation: results of a randomized trial, Int. J. Radiat. Oncol. Biol. Phys., 90 Tam, 2017, The effect of post-mastectomy radiation in women with one to three positive nodes enrolled on the control arm of BCIRG-005 at ten year follow-up, Radiother. Oncol., 123, 10, 10.1016/j.radonc.2017.03.001 Tendulkar, 2012, Impact of postmastectomy radiation on locoregional recurrence in breast cancer patients with 1–3 positive lymph nodes treated with modern systemic therapy, Int. J. Radiat. Oncol. Biol. Phys., 83, e577, 10.1016/j.ijrobp.2012.01.076 Velikova, 2018, Quality of life after postmastectomy radiotherapy in patients with intermediate-risk breast cancer (SUPREMO): 2-year follow-up results of a randomised controlled trial, Lancet Oncol., 19, 1516, 10.1016/S1470-2045(18)30515-1 Veronesi, 2003, A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer, N. Engl. J. Med., 349, 546, 10.1056/NEJMoa012782 Warren, 2014, The impact of radiation therapy on the risk of lymphedema after treatment for breast cancer: a prospective cohort study, Int. J. Radiat. Oncol. Biol. Phys., 88, 565, 10.1016/j.ijrobp.2013.11.232 Whelan, 2005, More evidence that locoregional radiation therapy improves survival: what should we do?, J. Natl. Cancer Inst., 97, 82, 10.1093/jnci/djh328 Zeidan, 2018, Postmastectomy radiation therapy in women with T1–T2 tumors and 1 to 3 positive lymph nodes: analysis of the breast international group 02-98 trial, Int. J. Radiat. Oncol. Biol. Phys., 101, 316, 10.1016/j.ijrobp.2018.01.105